Inhibitory effect of galanin on dopamine induced increased oxytocin secretion in rat neurohypophyseal tissue cultures

Regulatory Peptides

Volumn 116, Issue 1-3, 2003, Pages 35-41

  Galfi M ^a   Balaspiri L ^b   Toth R ^a   Pavo I ^b   Csajbok E ^b   Laszlo F ^c   Morschl, E ^c   Varga, Cs ^b   Laszlo F A ^b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Galanin regulation; Galanin dopamine interaction; Galantid; Neurohypophyseal tissue culture; Oxytocin

Indexed keywords

APOMORPHINE; DOPAMINE; GALANIN; GALANTID; OXYTOCIN; PEPTIDE DERIVATIVE; PROLYLLYSYLGLYCINE; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; INCUBATION TIME; MALE; NEUROHYPOPHYSIS; NONHUMAN; OXYTOCIN RELEASE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; TISSUE CULTURE;

EID: 0242329829     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(03)00190-3     Document Type: Article

References (70)

1. László F.A., Gálfi M., Jójárt I., Vecsernyés M., Laczi F., Maderschpach K. Neurohypophysis tissue culture as a model of hormonal activity of rat pituicytes. Thorn N.A., Vilhardt H., Treiman M. New aspects of morphology function and regulation, 4th int. conf. neurohypophysis, Coppenhagen. 1989;87-89 Oxford Univ. Press.
2. Janáky T., Szabó P., Kele Z., Baláspiri L., Varga C., Gálfi M.et al. Identification of oxytocin and vasopressin from neurohypophyseal cell culture. Rapid Commun. Mass Spectrom. 12:1998;1765-1768.
3. Tatemoto K., Rokaeus A., Jornvall H., McDonald T.J., Mutt V. Galanin - a novel biologically active peptide from porcine intestine. FEBS Lett. 164:1983;124-128.
4. Melander T., Hokfelt T., Rokaeus A. Distribution of galanin-like immunoreactivity in the rat central nervous system. J. Comp. Neurol. 248:1986;475-517.
5. Skofitsch G., Jacobowitz D.M. Immunohistochemical mapping of galanin-like neurons in the rat central nervous system. Peptides. 6:1985;509-546.
6. Palkovits M., Rokaeus A., Antoni F.A., Kiss A. Galanin in the hypothalamo-hypophyseal system. Neuroendocrinology. 46:1987;417-423.
7. Melander T., Hokfelt T., Rokaeus A., Cuello A.C., Oertel W.H., Verhofstad A.et al. Coexistence of galanin-like immunoreactivity with catecholamines, 5-hydroxytryptamine, GABA and neuropeptides in the rat CNS. J. Neurosci. 6:1986;3640-3654.
8. Skofitsch G., Jacobowitz D.M., Amann R., Lembeck F. Galanin and vasopressin coexist in the rat hypothalamo-neurohypophyseal system. Neuroendocrinology. 49:1989;419-427.
9. Rokaeus A., Young W.S. III, Mezey E. Galanin coexists with vasopressin in the normal rat hypothalamus and galanin's synthesis is increased in the Brattleboro (diabetes insipidus) rat. Neurosci. Lett. 90:1988;45-50.
10. Gaymann W., Martin R. Immunoreactive galanin-like material in magnocellular hypothalamo-neurohypophysial neurones of the rat. Cell Tissue Res. 255:1989;139-147.
11. Landry M., Trembleau A., Arai R., Calas A. Evidence for a colocalization of oxytocin mRNA and galanin in magnocellular hypothalamic neurons: a study combining in situ hybridization and immunohistochemistry. Brain Res. Mol. Brain Res. 10:1991;91-95.
12. Levin M.C., Sawchenko P.E. Neuropeptide co-expression in the magnocellular neurosecretory system of the female rat: evidence for differential modulation by estrogen. Neuroscience. 54:1993;1001-1018.
13. Meister B., Villar M.J., Ceccatelli S., Hokfelt T. Localization of chemical messengers in magnocellular neurons of the hypothalamic supraoptic and paraventricular nuclei: an immunohistochemical study using experimental manipulations. Neuroscience. 37:1990;603-633.
14. Landry M., Roche D., Angelova E., Calas A. Expression of galanin in hypothalamic magnocellular neurones of lactating rats: co-existence with vasopressin and oxytocin. J. Endocrinol. 155:1997;467-481.
15. Eriksson M., Ceccatelli S., Uvnas-Moberg K., Iadarola M., Hokfelt T. Expression of Fos-related antigens, oxytocin, dynorphin and galanin in the paraventricular and supraoptic nuclei of lactating rats. Neuroendocrinology. 63:1996;356-367.
16. Van Tol H.H., Bolwerk E.L., Liu B., Burbach J.P. Oxytocin and vasopressin gene expression in the hypothalamo-neurohypophyseal system of the rat during the estrous cycle, pregnancy, and lactation. Endocrinology. 122:1988;945-951.
17. Zingg H.H., Lefebvre D.L. Oxytocin and vasopressin gene expression during gestation and lactation. Brain Res. 464:1988;1-6.
18. Crowley R.S., Insel T.R., O'Keefe J.A., Amico J.A. Cytoplasmic oxytocin and vasopressin gene transcripts decline postpartum in the hypothalamus of the lactating rat. Endocrinology. 133:1993;2704-2710.
19. Mezey E., Kiss J.Z. Coexpression of vasopressin and oxytocin in hypothalamic supraoptic neurons of lactating rats. Endocrinology. 129:1991;1814-1820.
20. Boersma C.J., Van Leeuwen F.W. Neuron-glia interactions in the release of oxytocin and vasopressin from the rat neural lobe: the role of opioids, other neuropeptides and their receptors. Neuroscience. 62:1994;1003-1020.
21. Gálfi M., Janáky T., Tóth R., Prohászka G., Juhász A., Varga C.et al. Effects of dopamine and dopamine-active compounds on oxytocin and vasopressin production in rat neurohypophyseal tissue cultures. Regul. Pept. 98:2001;49-54.
22. Nordstrom O., Melander T., Hokfelt T., Bartfai T., Goldstein M. Evidence for an inhibitory effect of the peptide galanin on dopamine release from the rat median eminence. Neurosci. Lett. 73:1987;21-26.
23. Melander T., Fuxe K., Harfstrand A., Eneroth P., Hokfelt T. Effects of intraventricular injections of galanin on neuroendocrine functions in the male rat. Possible involvement of hypothalamic catecholamine neuronal systems. Acta Physiol. Scand. 131:1987;25-32.
24. Jansson A., Fuxe K., Eneroth P., Agnati L.F. Centrally administered galanin reduces dopamine utilization in the median eminence and increases dopamine utilization in the medial neostriatum of the male rat. Acta Physiol. Scand. 135:1989;199-200.
25. Kennedy P.G., Lisak R.P., Raff M.C. Cell type-specific markers for human glial and neuronal cells in culture. Lab. Invest. 43:1980;342-351.
26. Michler-Stuke A., Bottenstein J.E. Proliferation of glial-derived cells in defined media. J. Neurosci. Res. 7:1982;215-228.
27. Huszti Z., Rimanóczy A., Juhász A., Magyar K. Uptake, metabolism, and release of [3H]-histamine by glial cells in primary cultures of chicken cerebral hemispheres. Glia. 3:1990;159-168.
28. Julesz J., Gálfi M., Molnár J., Vecsernyés M. Central effects of tricyclic compounds on the endocrine system - an in vitro study. Prog. Brain Res. 91:1992;89-92.
29. Gálfi M., Baláspiri L., Tóth R., Pávó I., László F., Morschl É.et al. Inhibitory effect of galanin on dopamine-induced enhanced vasopressin secretion in rat neurohypophyseal tissue cultures. Regul. Pept. 110:2002;17-23.
30. Bridges T.E., Hillhouse E.W., Jones M.T. The effect of dopamine on neurohypophysial hormone release in vivo and from the rat neural lobe and hypothalamus in vitro. J. Physiol. 260:1976;647-666.
31. van Heuven-Nolsen D., de Kloet E.R., Versteeg D.H. Pro-Leu-GlyNH2 affects dopamine and noradrenaline utilization in rat limbic-forebrain nuclei. Brain Res. 322:1984;213-218.
32. Woodman O.L., Lang W.J. Dopamine-induced vasodilatation in the isolated perfused rat kidney. Arch. Int. Pharmacodyn. Ther. 243:1980;228-235.
33. Vecsernyés M., Török A., Jójárt I., Laczi F., Penke B., Julesz J. Specific radioimmunoassay of oxytocin in rat plasma. Endocr. Regul. 28:1994;145-150.
34. Hunter W.M., Greenwood F.C. Preparation of iodine 131 labelled human growth hormone of high specific activity. Nature. 194:1962;495-496.
35. Janáky T., Tóth G., Penke B., Kovács K., László F.A. Iodination of peptide hormones and purification of iodinated peptides by HPLC. J. Lic. Chromatogr. 5:1982;1499-1507.
36. Landry M., Roche D., Calas A. Short-term effects of centrally administered galanin on the hyperosmotically stimulated expression of vasopressin in the rat hypothalamus. An in situ hybridization and immunohistochemistry study. Neuroendocrinology. 61:1995;393-404.
37. Hatton G.I. Emerging concepts of structure-function dynamics in adult brain: the hypothalamo-neurohypophysial system. Prog. Neurobiol. 34:1990;437-504.
38. Falke N. Modulation of oxytocin and vasopressin release at the level of the neurohypophysis. Prog. Neurobiol. 36:1991;465-484.
39. Gaymann W., Falke N. Galanin lacks binding sites in the porcine pituitary and has no detectable effect on oxytocin and vasopressin release from rat neurosecretory endings. Neurosci. Lett. 112:1990;114-119.
40. Bjorkstrand E., Hulting A.L., Meister B., Uvnas-Moberg K. Effect of galanin on plasma levels of oxytocin and cholecystokinin. NeuroReport. 4:1993;10-12.
41. Ohtaki T., Kumano S., Ishibashi Y., Ogi K., Matsui H., Harada M.et al. Isolation and cDNA cloning of a novel galanin-like peptide (GALP) from porcine hypothalamus. J. Biol. Chem. 274:1999;37041-37045.
42. Shen J., Larm J.A., Gundlach A.L. Galanin-like peptide mRNA in neural lobe of rat pituitary. Increased expression after osmotic stimulation suggests a role for galanin-like peptide in neuron-glial interactions and/or neurosecretion. Neuroendocrinology. 73:2001;2-11.
43. Swaab D.F., Nijveldt F., Pool C.W. Distribution of oxytocin and vasopressin in the rat supraoptic and paraventricular nucleus. J. Endocrinol. 67:1975;461-462.
44. Rhodes C.H., Morrell J.I., Pfaff D.W. Immunohistochemical analysis of magnocellular elements in rat hypothalamus: distribution and numbers of cells containing neurophysin, oxytocin, and vasopressin. J. Comp. Neurol. 198:1981;45-64.
45. Mohr E., Zhou A., Thorn N.A., Richter D. Rats with physically disconnected hypothalamo-pituitary tracts no longer contain vasopressin- oxytocin gene transcripts in the posterior pituitary lobe. FEBS Lett. 263:1990;332-336.
46. Mohr E., Fehr S., Richter D. Axonal transport of neuropeptide encoding mRNAs within the hypothalamo-hypophyseal tract of rats. Embo J. 10:1991;2419-2424.
47. Schafer M.K., Day R., Ortega M.R., Akil H., Watson S.J. Proenkephalin messenger RNA is expressed both in the rat anterior and posterior pituitary. Neuroendocrinology. 51:1990;444-448.
48. Gajkowska B., Viron A. Ultrastructural evidence for endogenous vasoactive intestine peptide-like immunoreactivity in neurohypophysis. Neuroendocr. Lett. 13:1990;389-391.
49. Martin D.L. Synthesis and release of neuroactive substances by glial cells. Glia. 5:1992;81-94.
50. Sumners C., Myers L.M., Kalberg C.J., Raizada M.K. Physiological and pharmacological comparisons of angiotensin II receptors in neuronal and astrocyte glial cultures. Prog. Neurobiol. 34:1990;355-385.
51. Hosli E., Hosli L. Receptors for neurotransmitters on astrocytes in the mammalian central nervous system. Prog. Neurobiol. 40:1993;477-506.
52. Boersma C.J., Van Leeuwen F.W., O'Brien W.G., Law G.J., Mason W.T.et al. Dynorphin 1-17 delays the vasopressin induced mobilization of intracellular calcium in cultured astrocytes from the rat neural lobe. J. Neuroendocrinol. 5:1993;583-590.
53. Luckman S.M., Bicknell R.J. Binding sites for atrial natriuretic peptide (ANP) on cultured pituicytes: lack of effect of ANP on release of neurohypophysial hormones in vitro. Neurosci. Lett. 123:1991;156-159.
54. Lutz-Bucher B., Hindelang-Gertner C., Di Scala-Guenot D., Strosser M.T., Koch B. Evidence of the presence of guanylate cyclase-coupled receptors for atrial natriuretic pepide on pituicytes of the neurohypophysis. Molec. Cell Neurosci. 2:1991;363-368.
55. Bicknell R.J., Luckman S.M., Inenaga K., Mason W.T., Hatton G.I. Beta-adrenergic and opioid receptors on pituicytes cultured from adult rat neurohypophysis: regulation of cell morphology. Brain Res. Bull. 22:1989;379-388.
56. Smithson K.G., Suarez I., Hatton G.I. Beta-adrenergic stimulation decreases glial and increases neural contact with the basal lamina in rat neurointermediate lobes incubated in vitro. J. Neuroendocrinol. 2:1990;693-699.
57. Stumpf W.E., Sar M. Autographic localization of oestrogen, androgen progestin, and glucocorticosteroid in "target tissues" and "non-target tissues" Pasqualini J. Receptors and mechanism of action of steroid hormones. 1976;41-84 Marcel Dekker, New York.
58. Meister B., Villar M.J., Schalling M., Ehrlich M., Greengard P., Hokfelt T. Demonstration of DARPP-32 in pituicytes of the neurohypophysis-decreased expression after administration of hyperosmotic stimuli. Acta Physiol. Scand. 137:1989;461-462.
59. Hatton G.I., Bicknell R.J., Hoyland J., Bunting R., Mason W.T. Arginine vasopressin mobilises intracellular calcium via V1-receptor activation in astrocytes (pituicytes) cultured from adult rat neural lobes. Brain Res. 588:1992;75-83.
60. Boersma C.J., Sonnemans M.A., Van Leeuwen F.W. Immunoelectron microscopic demonstration of oxytocin and vasopressin in pituicytes and in nerve terminals forming synaptoid contacts with pituicytes in the rat neural lobe. Brain Res. 611:1993;117-129.
61. Burnard D.M., Pittman Q.J., MacVicar B.A. Neurotransmitter mediated changes in the electrophysiological properties of pituicytes. J. Neuroendocrinol. 3:1991;433-439.
62. Buijs R.M., Geffard M., Pool C.W., Hoorneman E.M. The dopaminergic innervation of the supraoptic and paraventricular nucleus. A light and electron microscopical study. Brain Res. 323:1984;65-72.
63. Lindvall O., Bjorklund A., Skagerberg G. Selective histochemical demonstration of dopamine terminal systems in rat di-and telencephalon: new evidence for dopaminergic innervation of hypothalamic neurosecretory nuclei. Brain Res. 306:1984;19-30.
64. Stefanini E., Devoto P., Marchisio A.M., Vernaleone F., Collu R. [3H]Spiroperidol binding to a putative dopaminergic receptor in rat pituitary gland. Life Sci. 26:1980;583-587.
65. Leibowitz S.F., Jhanwar-Uniyal M., Dvorkin B., Makman M.H. Distribution of alpha-adrenergic, beta-adrenergic and dopaminergic receptors in discrete hypothalamic areas of rat. Brain Res. 233:1982;97-114.
66. Holzbauer M., Sharman D.F., Godden U., Mann S.P., Stephens D.B. Effect of water and salt intake on pituitary catecholamines in the rat and domestic pig. Neuroscience. 5:1980;1959-1968.
67. Oki Y., Ohgo S., Yoshimi T. Effects of water deprivation and administration of hypertonic saline on dopamine concentrations in posterior pituitary and vasopressin release in rats. Brain Res. 348:1985;9-14.
68. Bartfai T., Bedecs K., Land T., Langel U., Bertorelli R., Girotti P.et al. M-15: high-affinity chimeric peptide that blocks the neuronal actions of galanin in the hippocampus, locus coeruleus, and spinal cord. Proc. Natl. Acad. Sci. U. S. A. 88:1991;10961-10965.
69. Lindskog S., Ahren B., Land T., Langel U., Bartfai T. The novel high-affinity antagonist, galantide, blocks the galanin-mediated inhibition of glucose-induced insulin secretion. Eur. J. Pharmacol. 210:1992;183-188.
70. Ogren S.O., Pramanik A., Land T., Langel U. Differential effects of the putative galanin receptor antagonists M15 and M35 on striatal acetylcholine release. Eur. J. Pharmacol. 242:1993;59-64.